UBS Group
HAIAW

UBS Group’s Healthcare AI Acquisition Corp. Warrants HAIAW Stock Holding History

UBS Group’s Portfolio HAIAW Stock Details HAIAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,941
Closed -$85 – 10091
2023
Q3 		$85 Buy
+1,941
New +$122 ﹤0.01% 8924
2023
Q2 		– Sell
-732
Closed -$73 – 9878
2023
Q1 		$73 Buy
+732
New +$71 ﹤0.01% 9288
2022
Q4 		– Sell
-1,039
Closed – – 11279
2022
Q3 		$0 Hold
1,039
– – ﹤0.01% 11108
2022
Q2 		$0 Buy
+1,039
New +$247 ﹤0.01% 11117

Other funds holding HAIAW

PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

UBS Group's HAIAW Position: Q4 2023 in Review

UBS Group sold out of Healthcare AI Acquisition Corp. Warrants (HAIAW) in Q4 2023, closing a stake of 1,941 shares — an estimated $85 sold.

UBS Group first reported a position in HAIAW in Q2 2022 and held it in 4 quarters. The position peaked at $85 in Q3 2023. 35 funds tracked by Wall St. Rank hold HAIAW as of Q4 2023.

  • UBS Group reported no remaining Healthcare AI Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
  • UBS Group sold 1,941 Healthcare AI Acquisition Corp. Warrants shares in Q4 2023, an estimated $85.
  • UBS Group first reported a position in Healthcare AI Acquisition Corp. Warrants in Q2 2022 and held it in 4 quarters.
  • UBS Group's Healthcare AI Acquisition Corp. Warrants position peaked at $85 in Q3 2023.
  • 35 funds tracked by Wall St. Rank held Healthcare AI Acquisition Corp. Warrants as of Q4 2023.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.